MetLife Investment Management’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,469
| Closed | -$157K | – | 2275 |
|
|
2020
Q3 | $157K | Hold |
1,469
| – | – | ﹤0.01% | 2004 |
|
|
2020
Q2 | $223K | Buy |
1,469
+346
| +31% | +$52.5K | ﹤0.01% | 1846 |
|
|
2020
Q1 | $93.5K | Hold |
1,123
| – | – | ﹤0.01% | 2110 |
|
|
2019
Q4 | $190K | Hold |
1,123
| – | – | ﹤0.01% | 2005 |
|
|
2019
Q3 | $208K | Sell |
1,123
-442
| -28% | -$82.1K | ﹤0.01% | 1922 |
|
|
2019
Q2 | $358K | Buy |
1,565
+430
| +38% | +$98.4K | ﹤0.01% | 1685 |
|
|
2019
Q1 | $239K | Hold |
1,135
| – | – | ﹤0.01% | 1886 |
|
|
2018
Q4 | $131K | Hold |
1,135
| – | – | ﹤0.01% | 2157 |
|
|
2018
Q3 | $260K | Hold |
1,135
| – | – | ﹤0.01% | 1940 |
|
|
2018
Q2 | $253K | Hold |
1,135
| – | – | ﹤0.01% | 1806 |
|
|
2018
Q1 | $259K | Hold |
1,135
| – | – | ﹤0.01% | 1754 |
|
|
2017
Q4 | $297K | Buy |
+1,135
| New | +$297K | ﹤0.01% | 1716 |
|